Logo image of BON

BON NATURAL LIFE LTD-A (BON) Stock Fundamental Analysis

USA - NASDAQ:BON - KYG144922047 - Common Stock

1.98 USD
+0.06 (+3.13%)
Last: 9/29/2025, 1:00:33 PM
Fundamental Rating

4

Taking everything into account, BON scores 4 out of 10 in our fundamental rating. BON was compared to 83 industry peers in the Chemicals industry. BON has an average financial health and profitability rating. BON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BON had positive earnings in the past year.
BON had a negative operating cash flow in the past year.
BON had positive earnings in each of the past 5 years.
In multiple years BON reported negative operating cash flow during the last 5 years.
BON Yearly Net Income VS EBIT VS OCF VS FCFBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

BON has a Return On Assets of 0.64%. This is comparable to the rest of the industry: BON outperforms 50.60% of its industry peers.
BON has a Return On Equity of 0.91%. This is comparable to the rest of the industry: BON outperforms 51.81% of its industry peers.
BON has a worse Return On Invested Capital (2.44%) than 61.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BON is above the industry average of 6.34%.
The last Return On Invested Capital (2.44%) for BON is well below the 3 year average (8.52%), which needs to be investigated, but indicates that BON had better years and this may not be a problem.
Industry RankSector Rank
ROA 0.64%
ROE 0.91%
ROIC 2.44%
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
BON Yearly ROA, ROE, ROICBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BON has a Profit Margin (1.67%) which is in line with its industry peers.
In the last couple of years the Profit Margin of BON has declined.
BON has a Operating Margin (7.86%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BON has declined.
Looking at the Gross Margin, with a value of 29.82%, BON is in line with its industry, outperforming 56.63% of the companies in the same industry.
BON's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.86%
PM (TTM) 1.67%
GM 29.82%
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
BON Yearly Profit, Operating, Gross MarginsBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BON is creating some value.
The number of shares outstanding for BON has been increased compared to 1 year ago.
BON has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BON has a worse debt to assets ratio.
BON Yearly Shares OutstandingBON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K
BON Yearly Total Debt VS Total AssetsBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BON has an Altman-Z score of 1.69. This is a bad value and indicates that BON is not financially healthy and even has some risk of bankruptcy.
BON's Altman-Z score of 1.69 is on the low side compared to the rest of the industry. BON is outperformed by 60.24% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that BON is not too dependend on debt financing.
BON's Debt to Equity ratio of 0.15 is amongst the best of the industry. BON outperforms 84.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 1.69
ROIC/WACC0.33
WACC7.34%
BON Yearly LT Debt VS Equity VS FCFBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 2.42 indicates that BON has no problem at all paying its short term obligations.
The Current ratio of BON (2.42) is better than 66.27% of its industry peers.
BON has a Quick Ratio of 2.32. This indicates that BON is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.32, BON belongs to the top of the industry, outperforming 83.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.32
BON Yearly Current Assets VS Current LiabilitesBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -97.84% in the last year.
The earnings per share for BON have been decreasing by -44.75% on average. This is quite bad
BON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.23%.
Measured over the past years, BON shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)-97.84%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%-95.59%
Revenue 1Y (TTM)-19.23%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-11.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
BON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.08% yearly.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON Yearly Revenue VS EstimatesBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
BON Yearly EPS VS EstimatesBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 50 100 150

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.73 indicates a rather cheap valuation of BON.
BON's Price/Earnings ratio is rather cheap when compared to the industry. BON is cheaper than 100.00% of the companies in the same industry.
BON's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.54.
Industry RankSector Rank
PE 0.73
Fwd PE N/A
BON Price Earnings VS Forward Price EarningsBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

96.39% of the companies in the same industry are more expensive than BON, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.06
BON Per share dataBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BON!.
Industry RankSector Rank
Dividend Yield N/A

BON NATURAL LIFE LTD-A

NASDAQ:BON (9/29/2025, 1:00:33 PM)

1.98

+0.06 (+3.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-22 2025-09-22
Earnings (Next)N/A N/A
Inst Owners0.73%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap8.02M
Analysts0
Price TargetN/A
Short Float %0.61%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.73
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.18
P/tB 0.19
EV/EBITDA 3.06
EPS(TTM)2.7
EY136.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-1.91
OCFYN/A
SpS5.89
BVpS10.84
TBVpS10.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 0.91%
ROCE 4.13%
ROIC 2.44%
ROICexc 2.44%
ROICexgc 2.48%
OM 7.86%
PM (TTM) 1.67%
GM 29.82%
FCFM N/A
ROA(3y)9.09%
ROA(5y)10.38%
ROE(3y)11.65%
ROE(5y)16.28%
ROIC(3y)8.52%
ROIC(5y)10.57%
ROICexc(3y)8.65%
ROICexc(5y)11.01%
ROICexgc(3y)8.8%
ROICexgc(5y)11.18%
ROCE(3y)13.84%
ROCE(5y)17.18%
ROICexcg growth 3Y-44.37%
ROICexcg growth 5Y-33.89%
ROICexc growth 3Y-44.35%
ROICexc growth 5Y-33.92%
OM growth 3Y-28.15%
OM growth 5Y-16.51%
PM growth 3Y-54.74%
PM growth 5Y-36.12%
GM growth 3Y2.25%
GM growth 5Y-1.53%
F-Score2
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA 2.24
Cap/Depr 0.64%
Cap/Sales 0.03%
Interest Coverage 6.18
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2.32
Altman-Z 1.69
F-Score2
WACC7.34%
ROIC/WACC0.33
Cap/Depr(3y)764.29%
Cap/Depr(5y)1250.29%
Cap/Sales(3y)6.63%
Cap/Sales(5y)12.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.84%
EPS 3Y-71.08%
EPS 5Y-44.75%
EPS Q2Q%-95.59%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.23%
Revenue growth 3Y-2.21%
Revenue growth 5Y7.78%
Sales Q2Q%-11.13%
Revenue Next Year77.63%
Revenue Next 2Y45.28%
Revenue Next 3Y34.64%
Revenue Next 5Y24.08%
EBIT growth 1Y-68.34%
EBIT growth 3Y-29.74%
EBIT growth 5Y-10.01%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-319.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1084.66%
OCF growth 3YN/A
OCF growth 5YN/A